Continuous Bioprocessing Market Report 2026

Continuous Bioprocessing Market Overview

• Continuous Bioprocessing market size has reached to $0.38 billion in 2025 • Expected to grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 21.5% • Growth Driver: Growing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Increasing Need For Flexible And Efficient Biologic Manufacturing Solutions • Market Trend: Advancement In Single-Use Technologies For Safer And Flexible Biologics Manufacturing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Continuous Bioprocessing Market?

Continuous bioprocessing is a manufacturing approach in which biological products are produced through an uninterrupted flow of materials across integrated upstream and downstream operations. It enables continuous cultivation, separation, purification, and product recovery within a single streamlined process. This method improves production efficiency, maintains consistent product quality, and reduces processing time and operational costs in biopharmaceutical and biotechnology industries The main products of continuous bioprocessing include filtration systems and consumables, chromatography systems and consumables, cell culture media, buffers, and reagents, incubators and shakers, bioreactors, centrifuges, sterilizers, and other instruments and consumables. Filtration systems and consumables refer to equipment and materials used for the continuous separation and purification of biological products during manufacturing processes. These products are used across process types including upstream processes and downstream processes and are available for large scale, mid scale, and small scale operations. The various applications involved are vaccine production, antibody production, cell and gene therapy, enzyme production, recombinant protein production, and others and they are utilized by end users including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic research institutes and laboratories.

What Is The Continuous Bioprocessing Market Growth Forecast?

The continuous bioprocessing market size is expected to see exponential growth in the next few years. It will grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 21.5%. The growth in the forecast period can be attributed to growing demand for cell and gene therapies, increasing investments in advanced bioprocessing facilities, rising demand for scalable manufacturing platforms, increasing adoption of automated process monitoring systems, expansion of personalized medicine development. Major trends in the forecast period include increasing adoption of single-use processing systems, growing preference for integrated upstream and downstream workflows, rising demand for high-yield biomanufacturing processes, increasing focus on process consistency and quality control, expansion of continuous production methods for biologics manufacturing.

Global Continuous Bioprocessing Market Segmentation

1) By Product: Filtration Systems And Consumables; Chromatography Systems And Consumables; Cell Culture Media, Buffers, And Reagents; Incubators And Shakers; Bioreactors; Centrifuges; Sterilizers; Other Instruments And Consumables 2) By Process Type: Upstream Processes; Downstream Processes 3) By Scale: Large Scale; Mid Scale; Small Scale 4) By Application: Vaccine Production; Antibody Production; Cell And Gene Therapy; Enzyme Production; Recombinant Protein Production; Other Applications 5) By End User: Pharmaceutical And Biotechnology Companies; Contract Development And Manufacturing Organizations; Academic Research Institutes And Laboratories Subsegments: 1) By Filtration Systems And Consumables: Membrane Filtration Systems; Depth Filtration Systems; Tangential Flow Filtration Systems; Cartridge Filters; Filter Cartridges; Disposable Filtration Assemblies; Filtration Membranes; Filter Holders And Housings 2) By Chromatography Systems And Consumables: Liquid Chromatography Systems; Continuous Chromatography Systems; Chromatography Columns; Chromatography Resins; Buffer Preparation Systems; Fraction Collectors; Chromatography Tubing And Connectors; Disposable Chromatography Components 3) By Cell Culture Media, Buffers, And Reagents: Serum Free Media; Chemically Defined Media; Cell Culture Supplements; Buffer Solutions; Growth Factors; Cell Dissociation Reagents; Process Reagents; Nutrient Feed Solutions 4) By Incubators And Shakers: Carbon Dioxide Incubators; Refrigerated Incubators; Orbital Shakers; Incubator Shakers; Temperature Controlled Shakers; Benchtop Incubators; Floor Standing Incubators; Microplate Shakers 5) By Bioreactors: Single Use Bioreactors; Stainless Steel Bioreactors; Perfusion Bioreactors; Stirred Tank Bioreactors; Airlift Bioreactors; Packed Bed Bioreactors; Bubble Column Bioreactors; Wave Induced Bioreactors 6) By Centrifuges: Laboratory Centrifuges; Industrial Centrifuges; Continuous Flow Centrifuges; Ultracentrifuges; Refrigerated Centrifuges; Benchtop Centrifuges; Floor Standing Centrifuges; Disc Stack Centrifuges 7) By Sterilizers: Steam Sterilizers; Dry Heat Sterilizers; Chemical Sterilizers; Radiation Sterilizers; Filtration Sterilizers; Laboratory Sterilizers; Industrial Sterilizers; Automated Sterilization Systems 8) By Other Instruments And Consumables: Sensors And Probes; Sampling Devices; Tubing And Connectors; Fluid Transfer Systems; Disposable Bags And Containers; Process Monitoring Instruments

What Is The Driver Of The Continuous Bioprocessing Market?

The growing demand for personalized medicine is expected to propel the growth of the continuous bioprocessing market going forward. Personalized medicine is a medical approach that customizes medical treatment based on an individual’s genetic profile, biomarkers, and disease characteristics to improve therapeutic effectiveness and patient outcomes. The growing demand for personalized medicine is due to the increasing adoption of targeted and precision therapies tailored to individual patient profiles. Continuous bioprocessing supports personalized medicine by enabling flexible, scalable, and efficient production of small-batch, high-value biologics and advanced therapies while improving product consistency and reducing manufacturing timelines. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the continuous bioprocessing industry.

Key Players In The Global Continuous Bioprocessing Market

Major companies operating in the continuous bioprocessing market are Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Sartorius AG; Lonza Group AG; Repligen Corporation; 3M Company; Fujifilm Corporation; Asahi Kasei Corporation; Corning Incorporated; Entegris Inc.; Getinge AB; Eppendorf SE; Bio-Rad Laboratories; Meissner Filtration Products Inc.; Shimadzu Corporation; Hamilton Company; Adolf Kühner AG; PBS Biotech Inc.; Esco Lifesciences Group; Bio-Techne; SATAKE MultiMix Corporation

Global Continuous Bioprocessing Market Trends and Insights

Major companies operating in the continuous bioprocessing market are focusing on developing advanced single-use manufacturing solutions, such as integrated antibody drug conjugate processing platforms, to improve production efficiency, enhance contamination control, and support flexible biologics manufacturing. Integrated antibody drug conjugate processing platforms refer to specialized single-use systems designed to streamline the manufacturing, handling, and purification of antibody drug conjugates in biopharmaceutical production environments. For instance, in September 2024, Merck KGaA, a Germany-based science and technology company, launched the Mobius ADC Reactor, a single-use manufacturing solution designed to improve the safe and efficient production of antibody drug conjugates. The system supports high-potency bioprocessing applications by offering enhanced containment, disposable fluid paths, and flexible scalability, helping biopharmaceutical manufacturers optimize production workflows and reduce cross-contamination risks during continuous processing operations.

What Are Latest Mergers And Acquisitions In The Continuous Bioprocessing Market?

In August 2024, Merck KGaA, a Germany-based science and technology company, acquired Mirus Bio for $600 million. Through this acquisition, Merck aimed to strengthen its viral vector bioprocessing capabilities and expand its integrated solutions portfolio for cell and gene therapy manufacturing. The acquisition also enhanced Merck’s upstream bioprocessing offerings by incorporating Mirus Bio’s advanced transfection technologies, which are widely used in viral vector production processes. Mirus Bio is a US-based biotechnology company specializing in transfection reagents and gene delivery technologies used in viral vector-based cell and gene therapies.

Regional Outlook

North America was the largest region in the continuous bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Continuous Bioprocessing Market?

The continuous bioprocessing market includes revenues earned by entities by providing services such as continuous cell culture processing, process optimization, integrated biomanufacturing support, automation and monitoring solutions, and contract manufacturing for biologics production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The continuous bioprocessing market also includes sales of bioprocess skids, nutrient feed systems, aseptic transfer components, disposable bioprocess containers, inline dilution systems, microbial fermentation equipment, flow distribution manifolds, and integrated fluid handling systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Continuous Bioprocessing Market Report 2026?

The continuous bioprocessing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the continuous bioprocessing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.